Unjha Formulations reported a 73% year-on-year rise in profit after tax (PAT) to ₹0.70 crore for FY26. The company aims for 20-25% growth in FY27 and plans geographic expansion.
Unjha Formulations Reports Strong FY26 Performance, Eyes International Growth
For the fiscal year ending March 31, 2026, Unjha Formulations Ltd. reported a Profit After Tax (PAT) of ₹0.70 crore (₹70.47 lakh), a significant 73% increase from ₹0.41 crore (₹40.75 lakh) in the previous year.
Revenue for FY26 stood at ₹15.59 crore (₹1,558.52 lakh), up 12.5% from ₹13.86 crore (₹1,386.21 lakh) in FY25.
Reader Takeaway: Strong profit growth and debt-free status are positives; contingent tax liabilities are a concern.
What Just Happened
Unjha Formulations Ltd. announced its financial results for the fiscal year ending March 31, 2026. The company achieved a substantial 73% year-on-year growth in profit after tax (PAT), reaching ₹0.70 crore. Revenue also saw a healthy increase of 12.5% to ₹15.59 crore.
Why This Matters
The robust profit growth, coupled with a 12.5% revenue increase, indicates improved operational efficiency and market performance. The company's debt-free status provides financial flexibility for future expansion and strategic initiatives. Management's projection of 20-25% growth for FY27 signals confidence in sustained performance.
The Backstory
The company has consistently relied on third-party manufacturing agreements, maintaining key associations with established players like Reckitt Benckiser India Ltd., Karnataka Antibiotics & Pharmaceuticals Ltd., and Nutragenics Healthcare Pvt Ltd. This model allows for focused operational leverage.
What Changes Now
With a new Managing Director, Smt. Krutiben M. Patel, at the helm for a three-year term starting May 18, 2026, the company is set to pursue its strategic goals. These include expanding into new international markets like Bangladesh, Africa, and other parts of Asia.
Risks to Watch
Investors should monitor contingent liabilities related to tax demands from FY 2010-11 and FY 2011-12, amounting to ₹680 and ₹200 respectively. The board's decision not to recommend a dividend for the year suggests a focus on conserving resources for reinvestment.
Peer Comparison
(No peer comparison data available in the filing).
Context Metrics
- FY 2025-26 Revenue: ₹15.59 crore
- FY 2025-26 PAT: ₹0.70 crore
- PAT Growth YoY: +73%
- Revenue Growth YoY: +12.5%
- Projected FY 2026-27 Growth: 20% to 25%
- Debt Position (Mar 31, 2026): ₹-1.64 crore (Debt-free)
What to Track Next
Shareholders should closely watch the company's progress in expanding into targeted international markets and its ability to achieve the projected growth rates for FY27. The effective management of contingent liabilities will also be a key factor.